BU
MD icon

BBVA USA’s Pediatrix Medical MD Stock Holding History

BBVA USA’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$394K Sell
13,859
-2,337
-14% -$71.2K 0.02% 359
2021
Q2 		$488K Buy
+16,196
New +$478K 0.03% 348

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
SV
Starboard Value New York $4.57B AUM 4.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

BBVA USA's MD Position: Q3 2021 in Review

BBVA USA reduced its Pediatrix Medical (MD) stake by 14% in Q3 2021, selling an estimated $71.2K and leaving 13,859 shares worth $394K. The position accounts for 0.02% of the portfolio, ranked #359.

BBVA USA first reported a position in MD in Q2 2021 and has held it in 2 quarters since. The position peaked at $488K in Q2 2021. 220 funds tracked by Wall St. Rank hold MD as of Q3 2021.

  • BBVA USA held 13,859 shares of Pediatrix Medical worth $394K as of Q3 2021.
  • BBVA USA sold 2,337 Pediatrix Medical shares in Q3 2021, an estimated $71.2K.
  • Pediatrix Medical made up 0.02% of BBVA USA's portfolio in Q3 2021, its #359 holding.
  • BBVA USA first reported a position in Pediatrix Medical in Q2 2021 and has held it in 2 quarters since.
  • BBVA USA's Pediatrix Medical position peaked at $488K in Q2 2021.
  • 220 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2021.

Based on BBVA USA's 13F filing for Q3 2021, filed 4 Nov 2021.